872728-81-9 Dabigatran etexilate mesylate 99%

Lupin’s journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better tomorrow.  Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader.

Headquartered in Mumbai, India, Lupin is a global pharmaceutical leader with a footprint across the U.S., LATAM, APAC, EMEA and India, with products distributed in over 100 markets.  With a diverse portfolio of over 1,200 products, Lupin remains committed to its mission of making quality healthcare accessible to the communities we serve.  Our visionary Founder, Dr. Desh Bandhu Gupta, instilled in us the importance of offering quality, affordable and innovative medicines and being a responsible corporate citizen, making a positive difference to patients, communities and the environment.

Lupin has a network of 15 manufacturing sites, 7 research centers, and a dedicated workforce of over 22,000 professionals.  The company places emphasis on business excellence, R&D and innovation, patient centricity and quality and compliance to consistently deliver value to our stakeholders.  Lupin has also been at the forefront of leveraging digital solutions to serve patient needs.